Nisaurrahmah, N. et al. 2021. Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review. Journal of Drug Delivery and Therapeutics. 11, 1-s (Feb. 2021), 195–199. DOI:https://doi.org/10.22270/jddt.v11i1-s.4554.